Globe Life Inc. GL
We take great care to ensure that the data presented and summarized in this overview for GLOBE LIFE INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GL
View all-
Vanguard Group Inc Valley Forge, PA10.4MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.1MShares$741 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.12MShares$622 Million0.11% of portfolio
-
Invesco Ltd. Atlanta, GA3.71MShares$451 Million0.08% of portfolio
-
State Street Corp Boston, MA3.55MShares$431 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA2.61MShares$318 Million0.02% of portfolio
-
Morgan Stanley New York, NY1.74MShares$211 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL1.52MShares$185 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.47MShares$179 Million0.04% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.28MShares$156 Million0.12% of portfolio
Latest Institutional Activity in GL
Top Purchases
Top Sells
About GL
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Insider Transactions at GL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2025
|
James Matthew Darden Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
24,890
-21.77%
|
$3,011,690
$121.63 P/Share
|
|
Feb 11
2025
|
James Matthew Darden Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,890
+28.04%
|
$2,165,430
$87.6 P/Share
|
|
Feb 11
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
11,000
-19.99%
|
$1,331,000
$121.67 P/Share
|
|
Feb 11
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+26.86%
|
$957,000
$87.6 P/Share
|
|
Feb 07
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,650
-47.09%
|
$1,299,300
$122.54 P/Share
|
|
Feb 07
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,650
+37.15%
|
$1,065,000
$100.78 P/Share
|
|
Feb 07
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Open market or private sale
|
Direct |
30,000
-59.56%
|
$3,630,000
$121.8 P/Share
|
|
Feb 07
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+47.98%
|
$2,460,000
$82.56 P/Share
|
|
Jan 06
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
13,448
-23.4%
|
$1,506,176
$112.7 P/Share
|
|
Jan 06
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+33.06%
|
$1,392,000
$87.6 P/Share
|
|
Jan 06
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,500
-45.18%
|
$168,000
$112.32 P/Share
|
|
Jan 06
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+31.12%
|
$147,000
$98.32 P/Share
|
|
Jan 06
2025
|
Mark A Blinn Director |
SELL
Open market or private sale
|
Direct |
3,000
-36.94%
|
$339,000
$113.23 P/Share
|
|
Jan 06
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
9,000
-22.53%
|
$1,008,000
$112.92 P/Share
|
|
Jan 06
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+28.59%
|
$477,000
$53.61 P/Share
|
|
Jan 02
2025
|
Mary E Thigpen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+8.5%
|
-
|
|
Jan 02
2025
|
Cheryl Alston Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+14.56%
|
-
|
|
Jan 02
2025
|
Mark A Blinn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+16.49%
|
-
|
|
Jan 02
2025
|
James Brannen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+15.61%
|
-
|
|
Jan 02
2025
|
Alice S Cho Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+26.43%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 88.3K shares |
|---|---|
| Open market or private purchase | 20.8K shares |
| Exercise of conversion of derivative security | 119K shares |
| Bona fide gift | 330 shares |
| Discretionary transaction | 2.58K shares |
| Open market or private sale | 120K shares |
|---|---|
| Payment of exercise price or tax liability | 19.8K shares |
| Bona fide gift | 772 shares |